Mar 12, 2024 · Praluent (alirocumab) is an injectable medicine that is given under your skin which may be used in adults with cardiovascular disease to reduce the risk of heart attack, stroke, …

PRALUENT is an injectable prescription medicine used in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of chest pain conditions (unstable …

Learn about PRALUENT's easy-to-use pre-filled injection pen. Follow instructions on how to use PRALUENT or watch a self-injection training video. Read Important Safety Information on …

Aug 4, 2024 · Praluent (alirocumab) is commonly used for the following conditions. To lower the risk of heart attack, stroke, and chest pain requiring hospitalization in people with heart disease

The recommended starting dose of PRALUENT is 75 mg once every 2 weeks administered subcutaneously, or 300 mg once every 4 weeks (monthly) If the LDL-C response is …

Sep 4, 2022 · Praluent belongs to a group of medications called PCSK9 inhibitors. Keep reading to learn about Praluent’s side effects, uses, dosages, and more. * An active ingredient is what …

Aug 25, 2023 · Praluent is a brand-name solution for subcutaneous injection that’s prescribed to lower cholesterol and decrease risk of certain heart problems. Praluent contains the active …

The recommended starting dose of PRALUENT is 75 mg once every 2 weeks administered subcutaneously, since the majority of patients achieve sufficient LDL-C reduction with this …

Sep 3, 2024 · The recommended starting dosage of PRALUENT is either 75 mg once every 2 weeks or 300 mg once every 4 weeks administered subcutaneously. For patients receiving …

PRALUENT® is indicated to reduce the risk of myocardial infarction, stroke, and unstable angina requiring hospitalization in adults with established cardiovascular disease.